| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Middle East Respiratory Syndrome Coronavirus | 27 | 2020 | 8843 | 2.66 | Why? |
| Coronavirus OC43, Human | 4 | 2019 | 1157 | 1.53 | Why? |
| Immunity, Cellular | 8 | 2021 | 3614 | 1.36 | Why? |
| Viral Vaccines | 15 | 2021 | 7560 | 1.29 | Why? |
| Hepatitis B Vaccines | 2 | 2018 | 245 | 1.18 | Why? |
| Coronavirus, Canine | 3 | 2017 | 375 | 1.16 | Why? |
| Respiratory Tract Infections | 11 | 2019 | 6817 | 1.14 | Why? |
| Coronavirus NL63, Human | 5 | 2016 | 669 | 1.13 | Why? |
| Luciferases | 2 | 2016 | 378 | 1.06 | Why? |
| Hepacivirus | 4 | 2021 | 1509 | 0.99 | Why? |
| Recombinant Proteins | 10 | 2020 | 3786 | 0.98 | Why? |
| Phylogeny | 22 | 2021 | 13341 | 0.97 | Why? |
| Viral Envelope Proteins | 9 | 2021 | 3539 | 0.94 | Why? |
| Antibodies, Viral | 28 | 2021 | 51949 | 0.92 | Why? |
| Coronavirus | 20 | 2019 | 18339 | 0.92 | Why? |
| Viral Proteins | 7 | 2017 | 7370 | 0.90 | Why? |
| Mice, Inbred BALB C | 15 | 2021 | 5814 | 0.90 | Why? |
| Antibodies, Neutralizing | 21 | 2021 | 25288 | 0.88 | Why? |
| Genetic Linkage | 1 | 2021 | 87 | 0.88 | Why? |
| Recombination, Genetic | 3 | 2017 | 1265 | 0.87 | Why? |
| Genes, Reporter | 3 | 2019 | 472 | 0.87 | Why? |
| Morphogenesis | 1 | 2020 | 43 | 0.86 | Why? |
| Mice | 30 | 2021 | 21357 | 0.83 | Why? |
| Viral Structural Proteins | 2 | 2015 | 491 | 0.83 | Why? |
| Spike Glycoprotein, Coronavirus | 20 | 2021 | 37182 | 0.83 | Why? |
| Poxviridae | 1 | 2019 | 23 | 0.80 | Why? |
| Vaccines, Inactivated | 5 | 2021 | 1562 | 0.73 | Why? |
| Parvoviridae Infections | 2 | 2019 | 222 | 0.72 | Why? |
| Hepatitis B Core Antigens | 1 | 2018 | 76 | 0.71 | Why? |
| Multiplex Polymerase Chain Reaction | 3 | 2016 | 1439 | 0.71 | Why? |
| Immunization | 6 | 2018 | 2019 | 0.70 | Why? |
| Coronavirus Infections | 52 | 2020 | 253789 | 0.70 | Why? |
| Animals | 50 | 2021 | 78931 | 0.69 | Why? |
| Histocompatibility Antigen H-2D | 1 | 2016 | 21 | 0.68 | Why? |
| Betacoronavirus 1 | 1 | 2017 | 51 | 0.66 | Why? |
| Immunity, Humoral | 5 | 2019 | 4849 | 0.66 | Why? |
| Nucleocapsid Proteins | 3 | 2016 | 3120 | 0.64 | Why? |
| Hepatitis B Surface Antigens | 1 | 2018 | 305 | 0.62 | Why? |
| Vaccinia virus | 3 | 2019 | 346 | 0.61 | Why? |
| Vaccines, Subunit | 3 | 2018 | 1088 | 0.60 | Why? |
| Human bocavirus | 1 | 2016 | 142 | 0.60 | Why? |
| Genetic Vectors | 5 | 2019 | 1600 | 0.60 | Why? |
| Genome, Viral | 11 | 2020 | 13157 | 0.59 | Why? |
| Enterovirus D, Human | 1 | 2016 | 96 | 0.59 | Why? |
| Vaccines, Virus-Like Particle | 1 | 2018 | 312 | 0.59 | Why? |
| Hepatitis B virus | 3 | 2018 | 882 | 0.58 | Why? |
| Molecular Biology | 1 | 2017 | 139 | 0.58 | Why? |
| Peptides | 3 | 2019 | 2513 | 0.56 | Why? |
| Blotting, Western | 6 | 2016 | 863 | 0.55 | Why? |
| Cytoplasm | 1 | 2015 | 304 | 0.55 | Why? |
| Lentivirus | 2 | 2015 | 310 | 0.53 | Why? |
| Central Nervous System | 1 | 2019 | 701 | 0.53 | Why? |
| Antigens, Viral | 6 | 2020 | 6298 | 0.51 | Why? |
| Sequence Analysis | 1 | 2015 | 496 | 0.51 | Why? |
| Cell Nucleus | 1 | 2015 | 399 | 0.50 | Why? |
| Virology | 1 | 2017 | 489 | 0.50 | Why? |
| Real-Time Polymerase Chain Reaction | 7 | 2021 | 11367 | 0.49 | Why? |
| Molecular Sequence Data | 6 | 2017 | 3198 | 0.47 | Why? |
| Oligonucleotides | 1 | 2012 | 137 | 0.47 | Why? |
| Drug Administration Schedule | 1 | 2019 | 2324 | 0.46 | Why? |
| Disease Models, Animal | 13 | 2021 | 10998 | 0.46 | Why? |
| Glycoproteins | 1 | 2017 | 615 | 0.46 | Why? |
| Immunogenicity, Vaccine | 4 | 2021 | 4624 | 0.45 | Why? |
| China | 22 | 2021 | 50654 | 0.45 | Why? |
| Immunity, Mucosal | 1 | 2015 | 426 | 0.45 | Why? |
| Enterovirus Infections | 1 | 2016 | 404 | 0.45 | Why? |
| Gene Transfer Techniques | 1 | 2012 | 134 | 0.45 | Why? |
| Antibodies, Monoclonal | 5 | 2021 | 8041 | 0.44 | Why? |
| Lymphocyte Activation | 2 | 2021 | 2742 | 0.43 | Why? |
| Hepatitis B | 2 | 2017 | 888 | 0.43 | Why? |
| Peptide Fragments | 2 | 2012 | 2075 | 0.42 | Why? |
| Interferon-beta | 2 | 2021 | 979 | 0.42 | Why? |
| T-Lymphocytes | 4 | 2021 | 6670 | 0.41 | Why? |
| Reagent Kits, Diagnostic | 1 | 2020 | 2149 | 0.41 | Why? |
| Coronaviridae Infections | 2 | 2013 | 442 | 0.41 | Why? |
| Evolution, Molecular | 4 | 2017 | 3691 | 0.41 | Why? |
| Receptors, Virus | 4 | 2020 | 5659 | 0.40 | Why? |
| Epitopes, T-Lymphocyte | 3 | 2019 | 2262 | 0.40 | Why? |
| Epithelial Cells | 3 | 2020 | 3508 | 0.39 | Why? |
| Cross Reactions | 2 | 2020 | 4374 | 0.39 | Why? |
| Cell Line | 11 | 2021 | 12040 | 0.38 | Why? |
| Respiratory System | 3 | 2020 | 3213 | 0.38 | Why? |
| Base Sequence | 6 | 2021 | 3581 | 0.38 | Why? |
| Adjuvants, Immunologic | 2 | 2018 | 1709 | 0.37 | Why? |
| Adenoviridae | 1 | 2015 | 1151 | 0.37 | Why? |
| Proline | 2 | 2021 | 345 | 0.36 | Why? |
| Viral Regulatory and Accessory Proteins | 1 | 2013 | 482 | 0.36 | Why? |
| Virus Replication | 11 | 2021 | 14331 | 0.36 | Why? |
| Virion | 1 | 2017 | 1444 | 0.36 | Why? |
| Genes, Viral | 4 | 2020 | 1428 | 0.36 | Why? |
| Escherichia coli | 2 | 2013 | 1547 | 0.36 | Why? |
| Reverse Transcription | 4 | 2021 | 673 | 0.35 | Why? |
| Hepatitis C | 2 | 2017 | 1514 | 0.35 | Why? |
| Macaca mulatta | 5 | 2020 | 3716 | 0.34 | Why? |
| Membrane Glycoproteins | 4 | 2011 | 2273 | 0.34 | Why? |
| Humans | 85 | 2021 | 930598 | 0.33 | Why? |
| Interferons | 3 | 2020 | 2885 | 0.32 | Why? |
| Polymorphism, Genetic | 1 | 2014 | 1074 | 0.32 | Why? |
| Sequence Homology | 2 | 2020 | 448 | 0.32 | Why? |
| Zika Virus | 1 | 2019 | 1924 | 0.31 | Why? |
| Beijing | 3 | 2019 | 912 | 0.31 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 4 | 2016 | 13720 | 0.30 | Why? |
| Viral Matrix Proteins | 1 | 2013 | 1243 | 0.29 | Why? |
| Open Reading Frames | 3 | 2020 | 1898 | 0.28 | Why? |
| Antibody Specificity | 2 | 2020 | 1328 | 0.28 | Why? |
| Camelus | 3 | 2020 | 1425 | 0.28 | Why? |
| SARS Virus | 7 | 2020 | 13021 | 0.28 | Why? |
| Sequence Analysis, DNA | 4 | 2017 | 2830 | 0.27 | Why? |
| Coronaviridae | 1 | 2010 | 923 | 0.27 | Why? |
| Immunoglobulin G | 7 | 2020 | 21571 | 0.27 | Why? |
| RNA, Viral | 9 | 2021 | 32276 | 0.27 | Why? |
| Virus Internalization | 4 | 2019 | 7921 | 0.26 | Why? |
| Antiviral Agents | 11 | 2021 | 41703 | 0.26 | Why? |
| Vaccines, Synthetic | 4 | 2021 | 3231 | 0.25 | Why? |
| Autophagy | 1 | 2010 | 960 | 0.25 | Why? |
| Paramyxoviridae Infections | 2 | 2019 | 364 | 0.25 | Why? |
| Bronchoalveolar Lavage Fluid | 3 | 2020 | 2309 | 0.24 | Why? |
| Dogs | 4 | 2020 | 2529 | 0.24 | Why? |
| Immunization Schedule | 3 | 2020 | 1305 | 0.24 | Why? |
| Ferrets | 2 | 2020 | 1201 | 0.24 | Why? |
| Betacoronavirus | 14 | 2020 | 204454 | 0.24 | Why? |
| Genomics | 4 | 2021 | 3118 | 0.23 | Why? |
| DNA, Viral | 3 | 2020 | 2521 | 0.23 | Why? |
| Sequence Alignment | 2 | 2020 | 2109 | 0.23 | Why? |
| Vaccines, DNA | 2 | 2019 | 871 | 0.23 | Why? |
| Fluorescent Antibody Technique, Indirect | 2 | 2014 | 393 | 0.23 | Why? |
| Female | 36 | 2021 | 380317 | 0.23 | Why? |
| Receptors, CCR | 1 | 2021 | 26 | 0.23 | Why? |
| DNA Primers | 4 | 2016 | 1170 | 0.23 | Why? |
| Vero Cells | 9 | 2021 | 14117 | 0.22 | Why? |
| Sulfones | 1 | 2021 | 66 | 0.22 | Why? |
| Oleanolic Acid | 1 | 2021 | 82 | 0.21 | Why? |
| Luciferases, Renilla | 1 | 2019 | 20 | 0.21 | Why? |
| Dipeptidyl Peptidase 4 | 3 | 2019 | 1061 | 0.21 | Why? |
| Cricetinae | 2 | 2020 | 3344 | 0.21 | Why? |
| Gene Dosage | 1 | 2020 | 101 | 0.21 | Why? |
| Leucine | 1 | 2021 | 121 | 0.21 | Why? |
| Genotype | 3 | 2017 | 4697 | 0.21 | Why? |
| Flavanones | 1 | 2021 | 141 | 0.20 | Why? |
| Models, Molecular | 6 | 2021 | 7616 | 0.20 | Why? |
| Dog Diseases | 2 | 2017 | 745 | 0.20 | Why? |
| Membrane Transport Proteins | 1 | 2021 | 152 | 0.20 | Why? |
| Phenanthridines | 1 | 2019 | 33 | 0.20 | Why? |
| Amaryllidaceae Alkaloids | 1 | 2019 | 34 | 0.20 | Why? |
| Haplorhini | 2 | 2021 | 307 | 0.20 | Why? |
| Poxviridae Infections | 1 | 2019 | 31 | 0.20 | Why? |
| Mice, Transgenic | 4 | 2021 | 2739 | 0.19 | Why? |
| Urea | 1 | 2021 | 228 | 0.19 | Why? |
| Tropism | 1 | 2020 | 210 | 0.19 | Why? |
| Child, Preschool | 7 | 2021 | 36283 | 0.19 | Why? |
| Genetic Loci | 1 | 2021 | 439 | 0.19 | Why? |
| Transgenes | 1 | 2020 | 227 | 0.19 | Why? |
| Emetine | 1 | 2019 | 70 | 0.19 | Why? |
| Chromosomes, Human, Pair 3 | 1 | 2021 | 195 | 0.19 | Why? |
| Respirovirus Infections | 1 | 2019 | 90 | 0.19 | Why? |
| Gene Deletion | 2 | 2021 | 430 | 0.18 | Why? |
| Viral Fusion Protein Inhibitors | 1 | 2019 | 88 | 0.18 | Why? |
| Molecular Imaging | 1 | 2019 | 110 | 0.18 | Why? |
| Cyclopropanes | 1 | 2021 | 332 | 0.18 | Why? |
| Adenoviridae Infections | 1 | 2019 | 150 | 0.18 | Why? |
| Animals, Domestic | 1 | 2020 | 272 | 0.18 | Why? |
| Cytopathogenic Effect, Viral | 1 | 2020 | 635 | 0.18 | Why? |
| Crystallography, X-Ray | 4 | 2020 | 2689 | 0.18 | Why? |
| CHO Cells | 1 | 2020 | 831 | 0.18 | Why? |
| Vaccinia | 1 | 2017 | 32 | 0.17 | Why? |
| Amino Acid Sequence | 4 | 2019 | 6049 | 0.17 | Why? |
| Korea | 1 | 2017 | 89 | 0.17 | Why? |
| Drug Evaluation, Preclinical | 2 | 2020 | 3347 | 0.17 | Why? |
| Cricetulus | 1 | 2020 | 936 | 0.17 | Why? |
| Protease Inhibitors | 4 | 2021 | 3630 | 0.17 | Why? |
| Infant | 6 | 2021 | 30274 | 0.17 | Why? |
| Gene Editing | 1 | 2021 | 330 | 0.17 | Why? |
| Acute Disease | 3 | 2016 | 6029 | 0.17 | Why? |
| Circular Dichroism | 1 | 2016 | 154 | 0.16 | Why? |
| Male | 25 | 2021 | 367725 | 0.16 | Why? |
| Epitope Mapping | 2 | 2019 | 1240 | 0.16 | Why? |
| Pneumonia, Viral | 14 | 2020 | 243684 | 0.16 | Why? |
| Sensitivity and Specificity | 6 | 2021 | 22971 | 0.16 | Why? |
| Pyrrolidines | 1 | 2020 | 558 | 0.16 | Why? |
| Hepatitis B Antibodies | 1 | 2017 | 142 | 0.16 | Why? |
| Orthomyxoviridae | 2 | 2017 | 1168 | 0.16 | Why? |
| Enzyme-Linked Immunosorbent Assay | 3 | 2018 | 7868 | 0.15 | Why? |
| Electrophoresis, Polyacrylamide Gel | 1 | 2016 | 238 | 0.15 | Why? |
| Copepoda | 1 | 2015 | 2 | 0.15 | Why? |
| Sequence Homology, Amino Acid | 2 | 2016 | 945 | 0.15 | Why? |
| Enzyme-Linked Immunospot Assay | 1 | 2016 | 325 | 0.15 | Why? |
| I-kappa B Kinase | 1 | 2015 | 98 | 0.15 | Why? |
| Rabbits | 2 | 2020 | 1171 | 0.15 | Why? |
| Interferon Regulatory Factor-7 | 1 | 2015 | 234 | 0.15 | Why? |
| Mice, Inbred C57BL | 4 | 2021 | 5542 | 0.15 | Why? |
| Luminescent Measurements | 1 | 2020 | 924 | 0.15 | Why? |
| Molecular Epidemiology | 2 | 2021 | 1638 | 0.15 | Why? |
| Chloroquine | 3 | 2020 | 3152 | 0.14 | Why? |
| Cell Communication | 1 | 2017 | 396 | 0.14 | Why? |
| Th1 Cells | 1 | 2021 | 1228 | 0.14 | Why? |
| Neutralization Tests | 5 | 2020 | 6698 | 0.14 | Why? |
| Nucleoproteins | 1 | 2016 | 223 | 0.14 | Why? |
| Callithrix | 1 | 2016 | 288 | 0.14 | Why? |
| Cell Line, Tumor | 2 | 2020 | 3608 | 0.14 | Why? |
| Terminology as Topic | 1 | 2020 | 546 | 0.14 | Why? |
| Viral Load | 4 | 2020 | 15850 | 0.14 | Why? |
| Repetitive Sequences, Amino Acid | 1 | 2013 | 37 | 0.14 | Why? |
| Severe Acute Respiratory Syndrome | 6 | 2020 | 12361 | 0.14 | Why? |
| Inhibitory Concentration 50 | 1 | 2017 | 907 | 0.14 | Why? |
| HEK293 Cells | 5 | 2021 | 8394 | 0.13 | Why? |
| Cysteine Proteinase Inhibitors | 1 | 2021 | 675 | 0.13 | Why? |
| Picornaviridae Infections | 1 | 2019 | 544 | 0.13 | Why? |
| Interferon-Induced Helicase, IFIH1 | 1 | 2015 | 245 | 0.13 | Why? |
| HeLa Cells | 2 | 2015 | 1303 | 0.13 | Why? |
| Nose | 1 | 2020 | 1093 | 0.13 | Why? |
| Virus Attachment | 2 | 2020 | 1259 | 0.13 | Why? |
| High-Throughput Screening Assays | 2 | 2020 | 1783 | 0.13 | Why? |
| DEAD Box Protein 58 | 1 | 2015 | 250 | 0.13 | Why? |
| Antigen Presentation | 1 | 2016 | 524 | 0.13 | Why? |
| Adolescent | 10 | 2021 | 86841 | 0.13 | Why? |
| Interferon Regulatory Factor-3 | 1 | 2015 | 379 | 0.13 | Why? |
| Protein Conformation | 3 | 2019 | 4386 | 0.12 | Why? |
| Conserved Sequence | 1 | 2015 | 751 | 0.12 | Why? |
| Viral Nonstructural Proteins | 2 | 2021 | 4810 | 0.12 | Why? |
| CD8-Positive T-Lymphocytes | 3 | 2020 | 5837 | 0.12 | Why? |
| Cloning, Molecular | 1 | 2016 | 1036 | 0.12 | Why? |
| Serologic Tests | 3 | 2012 | 4359 | 0.12 | Why? |
| Pharynx | 1 | 2020 | 1544 | 0.12 | Why? |
| Colorimetry | 1 | 2016 | 458 | 0.12 | Why? |
| Cells, Cultured | 2 | 2020 | 5835 | 0.12 | Why? |
| Phosphorylation | 1 | 2015 | 1060 | 0.12 | Why? |
| Longitudinal Studies | 2 | 2018 | 9893 | 0.12 | Why? |
| Ferritins | 1 | 2021 | 2055 | 0.12 | Why? |
| Bronchoscopy | 1 | 2020 | 991 | 0.11 | Why? |
| Gene Expression | 2 | 2013 | 3332 | 0.11 | Why? |
| Adaptor Proteins, Signal Transducing | 1 | 2015 | 502 | 0.11 | Why? |
| Sputum | 1 | 2020 | 1720 | 0.11 | Why? |
| Picornaviridae | 1 | 2012 | 123 | 0.11 | Why? |
| Receptors, Immunologic | 1 | 2015 | 555 | 0.11 | Why? |
| Protein Interaction Domains and Motifs | 1 | 2019 | 2134 | 0.11 | Why? |
| Chiroptera | 2 | 2017 | 3530 | 0.11 | Why? |
| Adult | 15 | 2021 | 244371 | 0.11 | Why? |
| Child | 6 | 2021 | 70012 | 0.11 | Why? |
| Nucleic Acid Amplification Techniques | 2 | 2016 | 3388 | 0.11 | Why? |
| History, 20th Century | 1 | 2017 | 1282 | 0.11 | Why? |
| Hepatitis B Antigens | 1 | 2010 | 19 | 0.11 | Why? |
| Disease Reservoirs | 1 | 2020 | 1672 | 0.10 | Why? |
| Plasmids | 2 | 2011 | 840 | 0.10 | Why? |
| Plant Extracts | 1 | 2021 | 1514 | 0.10 | Why? |
| Epitopes | 3 | 2021 | 4113 | 0.10 | Why? |
| Recombinant Fusion Proteins | 1 | 2015 | 919 | 0.10 | Why? |
| Computational Biology | 2 | 2016 | 4514 | 0.10 | Why? |
| Respiratory Syncytial Virus Infections | 1 | 2019 | 1234 | 0.10 | Why? |
| Protein Engineering | 1 | 2013 | 536 | 0.10 | Why? |
| Young Adult | 8 | 2021 | 93724 | 0.10 | Why? |
| Feces | 2 | 2020 | 4235 | 0.10 | Why? |
| Virulence | 1 | 2017 | 2172 | 0.10 | Why? |
| Ribavirin | 1 | 2016 | 1182 | 0.10 | Why? |
| Metapneumovirus | 1 | 2012 | 465 | 0.09 | Why? |
| Immunization, Secondary | 1 | 2017 | 1649 | 0.09 | Why? |
| Nanoparticles | 1 | 2021 | 2040 | 0.09 | Why? |
| Zoonoses | 2 | 2020 | 3034 | 0.09 | Why? |
| Protein Binding | 4 | 2019 | 11430 | 0.09 | Why? |
| Peptidyl-Dipeptidase A | 2 | 2020 | 9659 | 0.09 | Why? |
| Lung | 5 | 2020 | 31049 | 0.09 | Why? |
| Middle East | 1 | 2013 | 1418 | 0.09 | Why? |
| Protein Structure, Tertiary | 1 | 2013 | 1565 | 0.09 | Why? |
| Syndrome | 1 | 2013 | 1310 | 0.09 | Why? |
| Peptide Hydrolases | 1 | 2016 | 1269 | 0.09 | Why? |
| Prevalence | 4 | 2019 | 25773 | 0.09 | Why? |
| High-Throughput Nucleotide Sequencing | 1 | 2020 | 3633 | 0.09 | Why? |
| Interferon Type I | 1 | 2021 | 2789 | 0.08 | Why? |
| Polymorphism, Single Nucleotide | 1 | 2021 | 3607 | 0.08 | Why? |
| Middle Aged | 12 | 2021 | 270681 | 0.08 | Why? |
| Cluster Analysis | 1 | 2015 | 3001 | 0.08 | Why? |
| Interferon-gamma | 1 | 2017 | 2711 | 0.08 | Why? |
| Transfection | 1 | 2010 | 864 | 0.08 | Why? |
| Disease Susceptibility | 1 | 2020 | 4002 | 0.08 | Why? |
| Host-Pathogen Interactions | 2 | 2018 | 11041 | 0.08 | Why? |
| Infant, Newborn | 2 | 2019 | 23105 | 0.08 | Why? |
| Macaca fascicularis | 2 | 2021 | 1009 | 0.08 | Why? |
| Whole Genome Sequencing | 1 | 2017 | 3239 | 0.08 | Why? |
| Multiple Organ Failure | 1 | 2015 | 1724 | 0.07 | Why? |
| Zika Virus Infection | 1 | 2019 | 1920 | 0.07 | Why? |
| Inpatients | 1 | 2021 | 5161 | 0.07 | Why? |
| Immunoassay | 1 | 2020 | 4485 | 0.07 | Why? |
| Drug Delivery Systems | 1 | 2014 | 1365 | 0.07 | Why? |
| Survival Analysis | 1 | 2018 | 7592 | 0.07 | Why? |
| Molecular Diagnostic Techniques | 1 | 2020 | 4239 | 0.07 | Why? |
| Species Specificity | 2 | 2020 | 1356 | 0.07 | Why? |
| Gene Expression Regulation, Viral | 1 | 2010 | 925 | 0.07 | Why? |
| Vaccination | 2 | 2021 | 19050 | 0.06 | Why? |
| Time Factors | 2 | 2018 | 31397 | 0.06 | Why? |
| Aged | 8 | 2021 | 215776 | 0.06 | Why? |
| Scutellaria baicalensis | 1 | 2021 | 30 | 0.06 | Why? |
| Brain | 1 | 2019 | 5133 | 0.06 | Why? |
| Protein Domains | 3 | 2020 | 6563 | 0.06 | Why? |
| Occupational Exposure | 1 | 2020 | 4742 | 0.06 | Why? |
| Pandemics | 15 | 2021 | 389249 | 0.06 | Why? |
| Polymerase Chain Reaction | 1 | 2016 | 6740 | 0.05 | Why? |
| Coronavirus 229E, Human | 1 | 2009 | 1241 | 0.05 | Why? |
| Receptors, Complement 3d | 1 | 2020 | 60 | 0.05 | Why? |
| Ducks | 1 | 2020 | 120 | 0.05 | Why? |
| Sulfonic Acids | 1 | 2020 | 205 | 0.05 | Why? |
| Tight Junctions | 1 | 2020 | 179 | 0.05 | Why? |
| Double-Blind Method | 2 | 2021 | 5988 | 0.05 | Why? |
| Guinea Pigs | 1 | 2020 | 420 | 0.05 | Why? |
| Sus scrofa | 1 | 2020 | 205 | 0.05 | Why? |
| Immunoglobulin M | 1 | 2016 | 9091 | 0.05 | Why? |
| Dexamethasone | 1 | 2010 | 2055 | 0.04 | Why? |
| Rats, Wistar | 1 | 2020 | 621 | 0.04 | Why? |
| Solubility | 1 | 2019 | 382 | 0.04 | Why? |
| In Vitro Techniques | 1 | 2021 | 1027 | 0.04 | Why? |
| Microscopy, Electron, Transmission | 1 | 2020 | 605 | 0.04 | Why? |
| NF-E2-Related Factor 2 | 1 | 2021 | 373 | 0.04 | Why? |
| Reverse Genetics | 1 | 2021 | 439 | 0.04 | Why? |
| Virus Activation | 1 | 2021 | 480 | 0.04 | Why? |
| Hospitalization | 2 | 2019 | 54280 | 0.04 | Why? |
| Hydroxychloroquine | 1 | 2020 | 12447 | 0.04 | Why? |
| Macrophages, Alveolar | 1 | 2020 | 668 | 0.04 | Why? |
| Immune Tolerance | 1 | 2020 | 608 | 0.04 | Why? |
| Binding Sites | 2 | 2020 | 6201 | 0.04 | Why? |
| Nasopharynx | 2 | 2012 | 10224 | 0.04 | Why? |
| Immunodominant Epitopes | 1 | 2020 | 813 | 0.04 | Why? |
| Population Surveillance | 1 | 2012 | 4967 | 0.04 | Why? |
| Membrane Fusion | 1 | 2019 | 713 | 0.04 | Why? |
| A549 Cells | 1 | 2021 | 2066 | 0.03 | Why? |
| Influenza, Human | 1 | 2019 | 10779 | 0.03 | Why? |
| Chickens | 1 | 2020 | 1010 | 0.03 | Why? |
| Weight Loss | 1 | 2020 | 826 | 0.03 | Why? |
| RNA, Messenger | 2 | 2021 | 5131 | 0.03 | Why? |
| Administration, Inhalation | 1 | 2020 | 1647 | 0.03 | Why? |
| Catalytic Domain | 1 | 2020 | 1757 | 0.03 | Why? |
| Clinical Laboratory Techniques | 1 | 2020 | 23402 | 0.03 | Why? |
| Aged, 80 and over | 4 | 2021 | 88759 | 0.03 | Why? |
| Immunoenzyme Techniques | 1 | 2015 | 448 | 0.03 | Why? |
| Cats | 1 | 2020 | 1890 | 0.03 | Why? |
| Bronchi | 1 | 2020 | 1048 | 0.03 | Why? |
| Nigeria | 1 | 2020 | 2292 | 0.03 | Why? |
| Amino Acid Substitution | 1 | 2020 | 1706 | 0.03 | Why? |
| Crystallization | 1 | 2013 | 331 | 0.03 | Why? |
| Rats | 1 | 2020 | 2764 | 0.03 | Why? |
| Disease Outbreaks | 1 | 2021 | 27595 | 0.03 | Why? |
| Treatment Outcome | 1 | 2018 | 51732 | 0.03 | Why? |
| Cysteine Endopeptidases | 1 | 2020 | 1557 | 0.03 | Why? |
| Immunosuppressive Agents | 1 | 2010 | 6331 | 0.03 | Why? |
| Enzyme Inhibitors | 1 | 2021 | 1881 | 0.03 | Why? |
| Leukocytes, Mononuclear | 1 | 2020 | 2115 | 0.03 | Why? |
| Proteome | 1 | 2020 | 1812 | 0.03 | Why? |
| Chemokines | 1 | 2015 | 1095 | 0.02 | Why? |
| Protein Structure, Secondary | 1 | 2013 | 1077 | 0.02 | Why? |
| Dependovirus | 1 | 2010 | 272 | 0.02 | Why? |
| Immunologic Memory | 1 | 2021 | 3362 | 0.02 | Why? |
| Capsid Proteins | 1 | 2010 | 365 | 0.02 | Why? |
| Drug Discovery | 1 | 2021 | 3092 | 0.02 | Why? |
| Lymphocytes | 1 | 2020 | 3056 | 0.02 | Why? |
| Emergency Service, Hospital | 1 | 2012 | 14232 | 0.02 | Why? |
| B-Lymphocytes | 1 | 2021 | 4418 | 0.02 | Why? |
| Follow-Up Studies | 2 | 2017 | 17020 | 0.02 | Why? |
| CD4-Positive T-Lymphocytes | 1 | 2020 | 4545 | 0.02 | Why? |
| Drug Design | 1 | 2016 | 2627 | 0.02 | Why? |
| Radiography, Thoracic | 1 | 2020 | 5486 | 0.02 | Why? |
| Drug Repositioning | 1 | 2021 | 5683 | 0.01 | Why? |
| Genetic Variation | 1 | 2016 | 3919 | 0.01 | Why? |
| Disease Progression | 1 | 2020 | 13580 | 0.01 | Why? |
| Pneumonia | 1 | 2020 | 5652 | 0.01 | Why? |
| Reproducibility of Results | 1 | 2014 | 11304 | 0.01 | Why? |
| Biomarkers | 1 | 2020 | 23361 | 0.01 | Why? |
| Cohort Studies | 1 | 2020 | 36005 | 0.01 | Why? |
| Liver | 1 | 2010 | 4007 | 0.01 | Why? |
| Public Health | 1 | 2021 | 16359 | 0.01 | Why? |
| Cytokines | 1 | 2015 | 15010 | 0.01 | Why? |
| Severity of Illness Index | 1 | 2021 | 48226 | 0.01 | Why? |
| Research Design | 1 | 2007 | 5830 | 0.01 | Why? |
| Retrospective Studies | 1 | 2009 | 105322 | 0.00 | Why? |